Business
ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
TORONTO, Jan. 25 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and...
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\nTORONTO, Jan. 25 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology\ncompany discovering and developing the next wave of antibody therapeutics,\ntoday announced it will hold a conference call to discuss its fourth quarter\nand year end 2007 results at 8:00 a.m. (Eastern Time) on Tuesday, January 29,\n2008. The Company will report its results in a press release to be issued at\n7:00 a.m. prior to the call.\n\n\nDATE: Tuesday, January 29, 2008\n\nTIME: 8:00 a.m., Eastern Standard Time\n\nWEBCAST: A live audio webcast of the call will be available at\nwww.ariusmabs.com. Webcast attendees are welcome to listen to the conference\nin real-time or on-demand at their convenience. The webcast will be archived\nfor 365 days. Please connect to this website at least 15 minutes prior to the\nconference call to ensure adequate time for any software download that may be\nneeded to hear the webcast.\n\nTAPED REPLAY: 416-644-3414 or 1-800-731-6941 (Available until\n February 5, 2008)\n\nREFERENCE NUMBER: 21261080\n\n\nAbout ARIUS\n\n\nARIUS is a biotechnology company discovering and developing the next wave\nof antibody therapeutics. Established in 1999, ARIUS has built a proprietary\ntechnology platform, FunctionFIRST(TM), that rapidly identifies and selects\nantibodies based on their functional ability to affect disease. This antibody\ngeneration engine has enabled ARIUS to assemble a portfolio of more than 500\nantibody candidates. In addition to the antibodies it is developing in-house,\nARIUS has ongoing partnerships with key biotechnology and drug development\ncompanies. ARIUS is listed on the TSX under the symbol "ARI". For further\ninformation, visit www.ariusmabs.com\n\n\nForward-Looking Statements\n\n\nCertain statements in this news release constitute "forward-looking\nstatements" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statements are only predictions and actual\nevents...